Guillain-Barré syndrome: incidence and mortality rates in US hospitals.

作者: A. Alshekhlee , Z. Hussain , B. Sultan , B. Katirji

DOI: 10.1212/01.WNL.0000310983.38724.D4

关键词:

摘要: Objective: To determine the incidence, in-hospital mortality, and predictors of death in Guillain–Barre syndrome (GBS) a large US cohort. Methods: Our cohort was identified from Nationwide Inpatient Sample database, 2000 through 2004. We excluded patients younger than 18 years those who presented with rapidly paralyzing conditions due to other causes. GBS were transferred between hospitals counted once. The incidence rate adjusted for 20% census reported by Census Bureau. A logistic regression model used identify death. Results: After data cleansing, 4,954 primary diagnosis GBS. varied 1.65 1.79 per 100,000 during included this study. mortality 2.58% (128/4,954) did not change significantly over study period. Eleven percent had variable pulmonary complications, 9.1% received endotracheal intubation, which predictor (adjusted odds ratio 5.09, 95% CI 3.21–8.05). Other older age, composite comorbidity index, cardiac sepsis. Conclusion: is low, are similar predicting poor disability outcome. disease stable 5 GLOSSARY: ICD-9-CM = International Classification Diseases, 9th Revision, Clinical Modification; ICF intermediate care facility; IQR interquartile range; syndrome; NIS Sample; OR ratio; SNF skilled nursing facility.

参考文章(15)
ERNST F. HUND, CECIL O. BOREL, DAVID R. CORNBLATH, DANIEL F. HANLEY, GUY M. MCKHANN, Intensive management and treatment of severe Guillain-Barré syndrome. Critical Care Medicine. ,vol. 21, pp. 433- 446 ,(1993) , 10.1097/00003246-199303000-00023
A. Hiraga, M. Mori, K. Ogawara, T. Hattori, S. Kuwabara, Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes Neurology. ,vol. 61, pp. 471- 474 ,(2003) , 10.1212/01.WNL.0000081231.08914.A1
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
N. D. Lawn, E. F. M. Wijdicks, Fatal Guillain-Barré syndrome. Neurology. ,vol. 52, pp. 635- 635 ,(1999) , 10.1212/WNL.52.3.635
A. Chio, D. Cocito, M. Leone, M.T. Giordana, G. Mora, R. Mutani, , Guillain-Barré syndrome: A prospective, population-based incidence and outcome survey Neurology. ,vol. 60, pp. 1146- 1150 ,(2003) , 10.1212/01.WNL.0000055091.96905.D0
D. D. Fletcher, N. D. Lawn, T. D. Wolter, E. F. M. Wijdicks, Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation Neurology. ,vol. 54, pp. 2311- 2315 ,(2000) , 10.1212/WNL.54.12.2311
Graziella Bogliun, Ettore Beghi, Italian GBS Registry Study Group, None, Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996 Acta Neurologica Scandinavica. ,vol. 110, pp. 100- 106 ,(2004) , 10.1111/J.1600-0404.2004.00272.X
F.G.A. van der Meché, P.I.M. Schmitz, , A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome The New England Journal of Medicine. ,vol. 326, pp. 1123- 1129 ,(1992) , 10.1056/NEJM199204233261705
Richard A. C. Hughes, Jeremy H. Rees, Clinical and Epidemiologic Features of Guillain-Barré Syndrome The Journal of Infectious Diseases. ,vol. 176, ,(1997) , 10.1086/513793